51
|
Riddle MS, Ericsson CD, Gutierrez RL, Porter CK. Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs. J Travel Med 2018; 25:5127105. [PMID: 30312427 DOI: 10.1093/jtm/tay099] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Accepted: 10/10/2018] [Indexed: 12/21/2022]
Affiliation(s)
- Mark S Riddle
- Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
| | - Charles D Ericsson
- Department of Internal Medicine, McGovern Medical School, Houston, TX, USA
| | - Ramiro L Gutierrez
- Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, USA
| | - Chad K Porter
- Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, USA
| |
Collapse
|
52
|
Rodriguez-Valero N, Carbayo MJL, Sanchez DC, Vladimirov A, Espriu M, Vera I, Roldan M, de Alba T, Sanz S, Moreno JLG, Oroz ML, Muñoz J. Real-time incidence of travel-related symptoms through a smartphone-based app remote monitoring system: a pilot study. J Travel Med 2018; 25:4999197. [PMID: 29788400 DOI: 10.1093/jtm/tay034] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2018] [Accepted: 04/25/2018] [Indexed: 11/13/2022]
Abstract
Trip Doctor®, a Smartphone-based app monitoring system, was developed to detect infections among travelers in real-time. For testing, 106 participants were recruited (62.2% male, mean age 36 years (SD = 11)). Majority of trips were for tourism and main destinations were in South East Asia. Mean travel duration was 14 days (SD = 10). Diarrhea was the most frequently reported symptom (15.5%). The system demonstrated adequate usability and is ready to be used on a larger scale.
Collapse
Affiliation(s)
- N Rodriguez-Valero
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - M J Ledesma Carbayo
- Biomedical Image Technology, Electronic Engineering, Universidad Politécnica de Madrid & CIBER-BBN, Spain
| | - D Cuadrado Sanchez
- Biomedical Image Technology, Electronic Engineering, Universidad Politécnica de Madrid & CIBER-BBN, Spain
| | - A Vladimirov
- Biomedical Image Technology, Electronic Engineering, Universidad Politécnica de Madrid & CIBER-BBN, Spain
| | - M Espriu
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - I Vera
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - M Roldan
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - T de Alba
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - S Sanz
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| | - J L Gonzalez Moreno
- Biomedical Image Technology, Electronic Engineering, Universidad Politécnica de Madrid & CIBER-BBN, Spain
| | - M Luengo Oroz
- Biomedical Image Technology, Electronic Engineering, Universidad Politécnica de Madrid & CIBER-BBN, Spain
| | - J Muñoz
- ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic (Department of International Health), Universitat de Barcelona, Barcelona, Spain
| |
Collapse
|
53
|
Lääveri T, Vilkman K, Pakkanen SH, Kirveskari J, Kantele A. A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions. Clin Microbiol Infect 2017; 24:908.e9-908.e16. [PMID: 29133155 DOI: 10.1016/j.cmi.2017.10.034] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 09/12/2017] [Accepted: 10/24/2017] [Indexed: 11/24/2022]
Abstract
OBJECTIVES Eighty million travellers visiting (sub)tropical regions contract travellers' diarrhoea (TD) each year, yet prospective data comparing the prevalence of TD pathogens in various geographical regions are scarce. Our recent study using modern molecular methods found enteropathogenic (EPEC) and enteroaggregative (EAEC) Escherichia coli to be the most frequent pathogens, followed by enterotoxigenic E. coli (ETEC) and Campylobacter. We revisited our data to compare the findings by geographical region. METHODS A total of 459 prospectively recruited travellers provided stool samples and completed questionnaires before and after visiting destinations in various geographical regions. A multiplex quantitative real-time PCR assay was used to analyse Salmonella, Yersinia, Campylobacter jejuni/Campylobacter coli, Shigella, Vibrio cholerae, EPEC, EAEC, ETEC, enterohaemorrhagic E. coli and enteroinvasive E. coli. RESULTS TD was contracted by 69% (316/459) of the subjects; EPEC and EAEC outnumbered ETEC and Campylobacter in all regions. Multiple pathogens were detected in 42% (133/316) of the samples. The proportions of all pathogens varied by region. The greatest differences were seen for Campylobacter: while relatively frequent in South Asia (n = 11; 20% of the 55 with TD during travel) and Southeast Asia (15/84, 15%), it was less common in East and West Africa (5/71, 7% and 1/57, 2%) and absent in South America and the Caribbean (0/40). CONCLUSIONS EPEC and EAEC outnumbered ETEC and Campylobacter everywhere, yet the proportions of pathogen findings varied by region, with ETEC and Campylobacter rates showing the greatest differences. The high frequency of multibacterial findings in many regions indicates a need for further investigation of the clinical role of each pathogen.
Collapse
Affiliation(s)
- T Lääveri
- Inflammation Center, Division of Infectious Diseases, Helsinki University Hospital, Finland and University of Helsinki, Finland
| | - K Vilkman
- Inflammation Center, Division of Infectious Diseases, Helsinki University Hospital, Finland and University of Helsinki, Finland; Aava Travel Clinic, Medical Centre Aava, Helsinki, Finland
| | - S H Pakkanen
- Department of Bacteriology and Immunology, University of Helsinki, Finland
| | - J Kirveskari
- Department of Bacteriology, Helsinki University Hospital Laboratory (HUSLAB), Finland
| | - A Kantele
- Inflammation Center, Division of Infectious Diseases, Helsinki University Hospital, Finland and University of Helsinki, Finland; Aava Travel Clinic, Medical Centre Aava, Helsinki, Finland; Clinicum, University of Helsinki, Finland; Unit of Infectious Diseases, Department of Medicine/Solna, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|
54
|
Zöldi V, Sane J, Kantele A, Rimhanen-Finne R, Salmenlinna S, Lyytikäinen O. Destination specific risks of acquisition of notifiable food- and waterborne infections or sexually transmitted infections among Finnish international travellers, 1995-2015. Travel Med Infect Dis 2017; 25:35-41. [PMID: 29030321 DOI: 10.1016/j.tmaid.2017.10.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2017] [Revised: 09/22/2017] [Accepted: 10/09/2017] [Indexed: 11/30/2022]
Abstract
BACKGROUND Overnight international travels made by Finns more than doubled during 1995-2015. To estimate risks and observe trends of travel-related notifiable sexually transmitted and food- and water-borne infections (STIs and FWIs) among travellers, we analysed national reports of gonorrhoea, syphilis, hepatitis A, shigellosis, campylobacteriosis and salmonellosis cases and related them to travel statistics. METHOD Cases notified as travel-related to the Finnish infectious diseases register were used as numerators and overnight stays of Statistics Finland surveys as denominator. We calculated overall risks (per 100,000 travellers) and assessed trends (using regression model) in various geographic regions. RESULTS Of all travel-related cases during 1995-2015, 2304 were STIs and 70,929 FWIs. During 2012-2015, Asia-Oceania showed highest risk estimates for gonorrhoea (11.0; 95%CI, 9.5-13), syphilis (1.4; 0.93-2.1), salmonellosis (157; 151-164), and campylobacteriosis (135; 129-141), and Africa for hepatitis A (4.5; 2.5-7.9), and shigellosis (35; 28-43). When evaluating at country level, the highest risks of infections was found in Thailand, except for hepatitis A ranking Hungary the first. During 2000-2011, significantly decreasing trends occurred for most FWIs particularly in the European regions and for STIs in Russia-Baltics. CONCLUSIONS Our findings can be used in targeting pre-travel advice, which should also cover those visiting Thailand or European hepatitis A risk areas.
Collapse
Affiliation(s)
- Viktor Zöldi
- Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
| | - Jussi Sane
- Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
| | - Anu Kantele
- Infectious Diseases, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Unit of Infectious Diseases, Karolinska Institutet, Solna, Stockholm, Sweden.
| | - Ruska Rimhanen-Finne
- Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
| | - Saara Salmenlinna
- Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
| | - Outi Lyytikäinen
- Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
| |
Collapse
|
55
|
Angelo KM, Kozarsky PE, Ryan ET, Chen LH, Sotir MJ. What proportion of international travellers acquire a travel-related illness? A review of the literature. J Travel Med 2017; 24:3954792. [PMID: 28931136 PMCID: PMC5825178 DOI: 10.1093/jtm/tax046] [Citation(s) in RCA: 63] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/07/2017] [Indexed: 11/12/2022]
Abstract
INTRODUCTION As international travel increases, travellers may be at increased risk of acquiring infectious diseases not endemic in their home countries. Many journal articles and reference books related to travel medicine cite that between 22-64% of international travellers become ill during or after travel; however, this information is minimal, outdated and limited by poor generalizability. We aim to provide a current and more accurate estimate of the proportion of international travellers who acquire a travel-related illness. METHODS We identified studies via PubMed or travel medicine experts, published between January 1, 1976-December 31, 2016 that included the number of international travellers acquiring a travel-related illness. We excluded studies that focused on a single disease or did not determine a rate based on the total number of travellers. We abstracted information on traveller demographics, trip specifics, study enrollment and follow-up and number of ill travellers and their illnesses. RESULTS Of 743 studies, nine met the inclusion criteria. The data sources were from North America (four studies) and Europe (five studies). Most travellers were tourists, the most frequent destination regions were Asia and Africa, and the median trip duration ranged from 8-21 days. Six studies enrolled participants at the travellers' pre-travel consultation. All studies collected data through either extraction from the medical record, weekly diaries, or pre- and post-travel questionnaires. Data collection timeframes varied by study. Between 6-87% of travellers became ill across all studies. Four studies provided the best estimate: between 43-79% of travellers who frequently visited developing nations (e.g. India, Tanzania, and Kenya) became ill; travellers most frequently reported diarrhoea. CONCLUSION This is the most comprehensive assessment available on the proportion of international travellers that develop a travel-related illness. Additional cohort studies would provide needed data to more precisely determine the rates of illness in international travellers. KEYWORDS International travel, travel, illness.
Collapse
Affiliation(s)
- Kristina M Angelo
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA
| | - Phyllis E Kozarsky
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA.,Department of Medicine, Emory University, 1364 Clifton Rd NE, Atlanta, GA 30322, USA
| | - Edward T Ryan
- Massachusetts General Hospital Travelers' Advice and Immunization Center, 55 Fruit Street, Boston, MA 02114, USA.,Harvard Medical School, 25 Shattuck St., Boston, MA 02115, USA
| | - Lin H Chen
- Harvard Medical School, 25 Shattuck St., Boston, MA 02115, USA.,Mount Auburn Hospital, 330 Mt. Auburn St, Cambridge, MA, 02138, USA
| | - Mark J Sotir
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30329, USA
| |
Collapse
|
56
|
Kuenzli E, Juergensen D, Kling K, Jaeger VK, DeCrom S, Steffen R, Widmer AF, Battegay M, Hatz C, Neumayr A. Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia. J Travel Med 2017; 24:4085919. [PMID: 28931148 DOI: 10.1093/jtm/tax056] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/30/2017] [Indexed: 01/27/2023]
Abstract
BACKGROUND Travellers' diarrhoea is the most common health problem in travellers. Depending on the region visited, up to 40% of travellers develop diarrhoea during a 2-week trip. The aim of this study was to assess risk factors for TD among travellers to the Indian subcontinent. METHODS An observational prospective multicentre cohort study investigated travellers to the Indian subcontinent. Participants completed questionnaires assessing the incidence of travellers' diarrhoea and identifying potential risk factors. Covariates were assessed univariately, followed by a multivariate regression. RESULTS Two-hundred and twenty-six travellers were enrolled into the study, 178 filled in both pre- and post-travel questionnaires. Overall, the attack rate of travellers' diarrhoea was 38.2%. Travel destination is a key risk factor for the occurrence of TD. Travelling to India or Nepal vs Bhutan is associated with an increased risk for TD (OR 6.68 and 6.62, respectively). A length of stay of more than 3 weeks compared to less than 2 weeks is also associated with a significantly increased risk (OR 5.45). Having stayed in a high-risk area for travellers' diarrhoea within the past year before the current trip is associated with a significantly decreased risk (OR 0.19). No association was found between consumption of high risk food (i.e. tap water, ice cream, raw meat and hamburgers) and travellers' diarrhoea. CONCLUSION Travellers' diarrhoea is a frequent problem in travellers to the Indian subcontinent. Previous exposure in a high-risk area for travellers' diarrhoea within the past year appears to have a significant protective effect. Furthermore, an association between the occurrence of travellers' diarrhoea and travel destination and length of stay, respectively, was observed. Consumption of risk food did not confer a TD risk in our study.
Collapse
Affiliation(s)
- Esther Kuenzli
- Swiss Tropical and Public Health Institute Basel, University of Basel, Socinstrasse 57, Basel, Switzerland.,Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Hirschengraben 84, Zürich, Switzerland
| | - David Juergensen
- Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Hirschengraben 84, Zürich, Switzerland
| | - Kerstin Kling
- Swiss Tropical and Public Health Institute Basel, University of Basel, Socinstrasse 57, Basel, Switzerland
| | - Veronika K Jaeger
- Department of Rheumatology, Basel University Hospital, Petersgraben 4, Basel, Switzerland
| | - Susan DeCrom
- Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Hirschengraben 84, Zürich, Switzerland
| | - Robert Steffen
- Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Hirschengraben 84, Zürich, Switzerland
| | - Andreas F Widmer
- Division for Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Petersgraben 4, Basel, Switzerland
| | - Manuel Battegay
- Division for Infectious Diseases and Hospital Epidemiology, Basel University Hospital, Petersgraben 4, Basel, Switzerland
| | - Christoph Hatz
- Swiss Tropical and Public Health Institute Basel, University of Basel, Socinstrasse 57, Basel, Switzerland.,Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Hirschengraben 84, Zürich, Switzerland
| | - Andreas Neumayr
- Swiss Tropical and Public Health Institute Basel, University of Basel, Socinstrasse 57, Basel, Switzerland
| |
Collapse
|
57
|
Olanwijitwong J, Piyaphanee W, Poovorawan K, Lawpoolsri S, Chanthavanich P, Wichainprasast P, Tantawichien T. Health problems among Thai tourists returning from India. J Travel Med 2017; 24:3095985. [PMID: 28426113 DOI: 10.1093/jtm/tax013] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/14/2017] [Indexed: 11/13/2022]
Abstract
BACKGROUND The number of Thai tourists visiting India is increasing each year. Most studies investigating health problems among international travellers to India have focused on travellers from Europe or North America, and the applicability of these studies to Asian travellers is unknown. METHODS This cross-sectional study used data collected from Thai tourists who had recently completed a trip to India. A questionnaire on demographic data, travel characteristics, pre-travel health preparation, and health problems during the trip to India was administered. All participants were also invited to answer a follow-up questionnaire 15 days after their arrival. RESULTS The study included 1,304 Thai tourists returning from India between October 2014 and March 2015. Sixty-two percent were female. Overall median age was 49 years, and the median length of stay was 10.6 days. Most were package tourists, and 52% (675) reported health problems during their trip. Common health problems were cough, runny nose, and sore throat (31.1%), followed by musculoskeletal problems (21.7%), fever (12.7%), diarrhea (9.8%) and skin problems (6.6%). Other reported problems were related to the eyes/ears (2.1%), animal exposure (1.9%) and accidents (0.8%). We found that several factors may be associated with the incidence of health problems among these tourists, including travelling style and travel health preparation. In the follow-up questionnaire, 16.8% of the participants reported new or additional symptoms that developed after their return to Thailand. Respiratory symptoms were still the most common health problems during this 15-day period. CONCLUSIONS Over half (52%) of Thai tourists experienced health problems during their trip to India. The most common health problem was not travellers' diarrhoea, as would be expected from published studies. Rather, respiratory and musculoskeletal problems were common symptoms. This information will be useful in pre-travel assessment and care. Our findings may indicate that health risks among travellers vary by nationality.
Collapse
Affiliation(s)
- Jutarmas Olanwijitwong
- Faculty of Tropical Medicine, Hospital for Tropical Diseases, Mahidol University, Bangkok, Thailand
| | - Watcharapong Piyaphanee
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
| | - Kittiyod Poovorawan
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
| | - Saranath Lawpoolsri
- Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
| | - Pornthep Chanthavanich
- Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
| | - Pongdej Wichainprasast
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
| | - Terapong Tantawichien
- Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
| |
Collapse
|
58
|
Abstract
BACKGROUND Travellers' diarrhea (TD) continues to be the most frequent health problem in travellers with destinations in lower income parts of the world as compared with where they reside, even if that risk has slightly decreased. METHODS A systematic review was published 18 months ago; now PubMed was searched for more recent publications relating to travel, diarrhea, epidemiology, incidence, risk. RESULTS A trend to decreasing incidence rates have been noted in this as compared with the last century, but TD remains frequent. The clinical picture varies from a trivial ailment to severe with subsequent hospitalization. Of great concern are long-term sequelae, particularly post-infectious irritable bowel syndrome. The most important risk factors are the destination and duration of exposure among the environmental factors, whereas the age is the most relevant host factor. CONCLUSIONS Even if improved hygienic conditions in low-income countries often visited by travellers have resulted in slightly diminished incidence rates of TD, this remains a frequent health problem. Visitors to such destinations must be informed about that health risk and it is beneficial to equip them with instructions and a travel kit to enable them to some extent self-manage TD occurring abroad.
Collapse
Affiliation(s)
- Robert Steffen
- Epidemiology, Biostatistics and Prevention Institute, World Health Organization Collaborating Centre for Traveller's Health, University of Zurich, Zurich, Switzerland.,Division of Epidemiology Human Genetics & Environmental Sciences, The University of Texas School of Public Health, Houston, TX, USA
| |
Collapse
|
59
|
Kantele A, Mero S, Kirveskari J, Lääveri T. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study. Travel Med Infect Dis 2017; 16:23-30. [PMID: 28153711 DOI: 10.1016/j.tmaid.2017.01.003] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2017] [Revised: 01/24/2017] [Accepted: 01/26/2017] [Indexed: 02/02/2023]
Abstract
BACKGROUND One third of travellers to the poor regions of the (sub)tropics become colonized by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). Co-resistance to non-beta-lactam antibiotics complicates the treatment of potential ESBL-PE infections. METHODS We analysed co-resistance to non-beta-lactams among travel-acquired ESBL-PE isolates of 90 visitors to the (sub)tropics with respect to major risk factors of colonization: destination, age, travellers' diarrhoea (TD) and antibiotic (AB) use. RESULTS Of the ESBL-PE isolates, 53%, 52%, 73%, and 2% proved co-resistant to ciprofloxacin, tobramycin, co-trimoxazole, and nitrofurantoin, respectively. The rates were similar among those with (TD+) or without (TD-) travellers' diarrhoea. Among fluoroquinolone-users vs. AB non-users, the co-resistance rates for ciprofloxacin were 95% versus 37% (p = 0.001), for tobramycin 85% versus 43% (p = 0.005), co-trimoxazole 85% versus 68% (p = 0.146), and nitrofurantoin 5% versus 2% (p = 0.147). In multivariable analysis co-resistance to ciprofloxacin was associated with increasing age, fluoroquinolone use, and tobramycin resistance. CONLUSIONS While TD predisposes to ESBL-PE non-selectively, antimicrobial use favours strains resistant to drug taken and, simultaneously, any drug with resistance genetically linked to the drug used. Antibiotics taken during travel predispose to ESBL-PE with a high co-resistance rate.
Collapse
Affiliation(s)
- Anu Kantele
- Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, POB 348, FIN-00029 HUS, Helsinki, Finland; Aava Travel Clinic, Medical Centre Aava, Annankatu 32, FIN-00100 Helsinki, Finland; Unit of Infectious Diseases, Karolinska Institutet, Solna, SE-17176 Stockholm, Sweden.
| | - Sointu Mero
- Division of Clinical Microbiology, Helsinki University Hospital, HUSLAB, POB 400, FIN-00029 HUS, Helsinki, Finland.
| | - Juha Kirveskari
- Division of Clinical Microbiology, Helsinki University Hospital, HUSLAB, POB 400, FIN-00029 HUS, Helsinki, Finland.
| | - Tinja Lääveri
- Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, POB 348, FIN-00029 HUS, Helsinki, Finland.
| |
Collapse
|
60
|
Chen LH, Han PV, Wilson ME, Stoney RJ, Jentes ES, Benoit C, Ooi WW, Barnett ED, Hamer DH. Self-reported illness among Boston-area international travelers: A prospective study. Travel Med Infect Dis 2016; 14:604-613. [PMID: 27687076 PMCID: PMC5695040 DOI: 10.1016/j.tmaid.2016.09.009] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2016] [Revised: 09/14/2016] [Accepted: 09/16/2016] [Indexed: 01/09/2023]
Abstract
BACKGROUND The Boston Area Travel Medicine Network surveyed travelers on travel-related health problems. METHODS Travelers were recruited 2009-2011 during pre-travel consultation at three clinics. The investigation included pre-travel data, weekly during-travel diaries, and a post-travel questionnaire. We analyzed demographics, trip characteristics, health problems experienced, and assessed the relationship between influenza vaccination, influenza prevention advice, and respiratory symptoms. RESULTS Of 987 enrolled travelers, 628 (64%) completed all surveys, of which 400 (64%) reported health problems during and/or after travel; median trip duration was 12 days. Diarrhea affected the most people during travel (172) while runny/stuffy nose affected the most people after travel (95). Of those with health problems during travel, 25% stopped or altered plans; 1% were hospitalized. After travel, 21% stopped planned activities, 23% sought physician or other health advice; one traveler was hospitalized. Travelers who received influenza vaccination and influenza prevention advice had lower rates of respiratory symptoms than those that received influenza prevention advice alone (18% vs 28%, P = 0.03). CONCLUSIONS A large proportion of Boston-area travelers reported health problems despite pre-travel consultation, resulting in inconveniences. The combination of influenza prevention advice and influenza immunization was associated with fewer respiratory symptoms than those who received influenza prevention advice alone.
Collapse
Affiliation(s)
- Lin H Chen
- Travel Medicine Center, Mount Auburn Hospital, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.
| | - Pauline V Han
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Mary E Wilson
- Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Rhett J Stoney
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Emily S Jentes
- Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Christine Benoit
- Children's Hospitals and Clinics of Minnesota, Department of Research and Sponsored Programs, Minneapolis, MN, USA
| | - Winnie W Ooi
- Travel and Tropical Medicine Clinic, Lahey Clinic Medical Center, Burlington, MA, USA
| | - Elizabeth D Barnett
- Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Boston, MA, USA
| | - Davidson H Hamer
- Center for Global Health and Development, Boston University School of Public Health, Boston, MA, USA; Department of Global Health, Boston University School of Public Health, Boston, MA, USA; Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, USA.
| |
Collapse
|
61
|
Siikamäki H, Kivelä P, Fotopoulos M, Kantele A. A closer look at travellers' infections abroad: Finnish nationwide data with incidences, 2010 to 2012. Travel Med Infect Dis 2016; 15:29-36. [PMID: 27773779 DOI: 10.1016/j.tmaid.2016.10.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2016] [Revised: 10/08/2016] [Accepted: 10/18/2016] [Indexed: 11/16/2022]
Abstract
BACKGROUND Although infections represent the most common health problem of travellers abroad, data on morbidity and incidences of various infections are scarce. METHOD Data on infections of Finnish travellers during 2010-2012 were retrieved from the database of SOS International, an assistance organization covering 95% of Finns requiring aid abroad. The study included 30,086 cases. For incidence calculation, the data were linked to the numbers of Finns visiting these regions during the same period as recorded by the Official Statistics of Finland. RESULTS The incidence of infections was particularly high in Africa, southern Europe plus the eastern Mediterranean, and Asia plus Oceania. The most frequent diagnoses were acute gastroenteritis (38.0%) and respiratory-tract infections (RTI) (34.5%), followed by infections of the ear (12.6%), skin or subcutaneous tissue (5.1%), urogenital tract (4.2%), eye (3.1%), and systemic febrile infections (2.2%). Vaccine-preventable diseases (VPD) accounted for 0.8% of cases, with varicella as most (49%) and influenza as second-most (27%) common. CONCLUSIONS Incidence of infections was higher in southern than in eastern and western Europe. Gastroenteritis and RTI proved the most frequent diagnoses, whereas systemic febrile infections were uncommon. Despite pre-travel immunizations, VPDs still occurred; pre-travel consultation should cover both varicella and influenza.
Collapse
Affiliation(s)
- Heli Siikamäki
- Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, POB 348, FI-00029 HUS, Helsinki, Finland; SOS International, Nitivej 6, DK-2000, Frederiksberg, Denmark.
| | - Pia Kivelä
- Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, POB 348, FI-00029 HUS, Helsinki, Finland.
| | | | - Anu Kantele
- Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, POB 348, FI-00029 HUS, Helsinki, Finland; Karolinska Institute, Department of Medicine/Solna, Unit of Infectious Diseases, SE 17176 Stockholm, Sweden.
| |
Collapse
|
62
|
Armand-Lefevre L, Ruppé E, Andremont A. ESBL-producing Enterobacteriaceae in travellers: doctors beware. THE LANCET. INFECTIOUS DISEASES 2016; 17:8-9. [PMID: 27751773 DOI: 10.1016/s1473-3099(16)30417-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 09/26/2016] [Indexed: 12/23/2022]
Affiliation(s)
- Laurence Armand-Lefevre
- IAME, UMR 1137, INSERM, Paris Diderot University, Sorbonne Paris Cité, Bactériologie Laboratory, Hôpital Bichat, AP-HP, Paris 75013, France
| | - Etienne Ruppé
- Genomic Research Laboratory, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
| | - Antoine Andremont
- IAME, UMR 1137, INSERM, Paris Diderot University, Sorbonne Paris Cité, Bactériologie Laboratory, Hôpital Bichat, AP-HP, Paris 75013, France.
| |
Collapse
|